首页> 美国卫生研究院文献>World Journal of Diabetes >Classification of diabetic retinopathy and diabetic macular edema
【2h】

Classification of diabetic retinopathy and diabetic macular edema

机译:糖尿病性视网膜病变和糖尿病性黄斑水肿的分类

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The global incidence and prevalence of diabetes mellitus (DM) have reached epidemic proportions. Estimates indicate that more than 360 million people will be affected by DM by 2030. All of these individuals will be at risk of developing diabetic retinopathy (DR). It is extremely important to categorize, classify and stage the severity of DR in order to establish adequate therapy. With proper management more than 90% of cases of visual loss can be prevented. The purpose of the current paper is to review the classification of DR with a special emphasis on the International Clinical Disease Severity Scale for DR. This new classification is simple to use, easy to remember and based on scientific evidence. It does not require specialized examinations such as optical coherence tomography or fluorescein angiography. It is based on clinical examination and applying the Early Treatment of Diabetic Retinopathy Study 4:2:1 rule.
机译:糖尿病(DM)的全球发病率和患病率已达到流行病的比例。估计表明,到2030年,将有超过3.6亿人受到DM的影响。所有这些人都有患糖尿病性视网膜病(DR)的风险。为了建立适当的治疗方法,对DR的严重程度进行分类,分类和分级非常重要。通过适当的管理,可以防止90%以上的视力丧失。本文的目的是回顾DR的分类,特别着重于DR的国际临床疾病严重性量表。这种新的分类易于使用,易于记忆并且基于科学证据。它不需要专门的检查,例如光学相干断层扫描或荧光素血管造影。它基于临床检查,并应用糖尿病视网膜病变的早期治疗研究4:2:1规则。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号